Oboravo, Empagliflozin

Oboravo is used to treat Type-2 diabetes mellitus in adults.

Oboravo is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, and it works by increasing the amount of insulin produced by the pancreas which then reduces the level of sugar in the blood. Oboravo also works by decreasing the amount of sugar the body absorbs and increasing the amount of sugar that leaves the body in the urine.Oboravo increases the loss of sugar through the kidneys

Patients who take Oboravo may suffer from such side effects;

Nausea,
Frequent urge to urinate,
Increased thirst,
Bladder pain,
Bloody or cloudy urine,
Change in the color, amount, or odor of vaginal discharge,
Difficult, painful urination,
Lower back pain,
Pain during sexual intercourse,
Urinary tract infection,
Hypoglycaemia,
Genital fungal infection